Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Discovery Medicine
|
December 27, 2024
Mechanism of Interleukin-17A Regulation of Mesenchymal Stroma/Stem Cell Osteogenic Differentiation
Juan F Santibanez
ISRN Dermatology
|
August 29, 2013
Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer
Juan F Santibanez
Protein and Peptide Letters
|
August 19, 2017
Urokinase Type Plasminogen Activator and the Molecular Mechanisms of its Regulation in Cancer
Juan F Santibanez
Frontiers in Bioscience (Landmark Edition)
|
March 28, 2025
Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
Juan F Santibanez
Thescientificworldjournal
|
March 1, 2014
Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells
Jelena Krstic, Juan F Santibanez
Recent Patents on Anti-Cancer Drug Discovery
|
February 23, 2018
Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Juan F Santibanez, Suncica Bjelica
Current Protein & Peptide Science
|
November 1, 2017
Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer
Juan F Santibanez, Jelena Krstic
Biomolecular Concepts
|
December 2, 2014
Transforming growth factor-β superfamily, implications in development and differentiation of stem cells
Juan F Santibanez, Jelena Kocic
Journal of Clinical Medicine
|
July 2, 2021
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
Suncica Kapor, Juan F Santibanez
Cell Biology International
|
January 20, 2015
Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction
Sonja S Mojsilović, Juan F Santibanez
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Discovery Medicine
|
December 27, 2024
Mechanism of Interleukin-17A Regulation of Mesenchymal Stroma/Stem Cell Osteogenic Differentiation
Juan F Santibanez
ISRN Dermatology
|
August 29, 2013
Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer
Juan F Santibanez
Protein and Peptide Letters
|
August 19, 2017
Urokinase Type Plasminogen Activator and the Molecular Mechanisms of its Regulation in Cancer
Juan F Santibanez
Frontiers in Bioscience (Landmark Edition)
|
March 28, 2025
Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
Juan F Santibanez
Thescientificworldjournal
|
March 1, 2014
Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells
Jelena Krstic, Juan F Santibanez
Recent Patents on Anti-Cancer Drug Discovery
|
February 23, 2018
Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Juan F Santibanez, Suncica Bjelica
Current Protein & Peptide Science
|
November 1, 2017
Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer
Juan F Santibanez, Jelena Krstic
Biomolecular Concepts
|
December 2, 2014
Transforming growth factor-β superfamily, implications in development and differentiation of stem cells
Juan F Santibanez, Jelena Kocic
Journal of Clinical Medicine
|
July 2, 2021
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
Suncica Kapor, Juan F Santibanez
Cell Biology International
|
January 20, 2015
Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction
Sonja S Mojsilović, Juan F Santibanez
Page
of 7